Accessible, rapid testing transforms prostate cancer detection
By developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable
By developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable
Enhances quality control by providing absolute molecular weight of biologics and avoiding common errors encountered with other techniques
Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'
The Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.
Hear expert insights on ADC innovations, manufacturing challenges, and the future of precision medicine
New test format enhances commercialisation potential
Successful project delivery of Optimer binders with proven function as vaccine adjuvants